Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS), a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO CBRND) for advanced biologics manufacturing services-specifically, to manufacture an anti-Ebola monoclonal antibody (mAb). The award was made possible through c...